TrademarkDir
INTASYL
LIVE

Serial Number

88571383

Owner

PHIO PHARMACEUTICALS CORP.

Attorney

Sarah Anne Keefe

First Use Date

Jun 27, 2022

Filing Date

Aug 8, 2019

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

INTASYL Trademark

Serial Number: 88571383 • Registration: 7139368

INTASYL is a trademark filed by PHIO PHARMACEUTICALS CORP. on August 8, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

PHIO PHARMACEUTICALS CORP. (16 trademarks)

MARLBOROUGH, MA 01752

Entity Type: 03

Trademark Details

Filing Date

August 8, 2019

Registration Date

August 15, 2023

First Use Anywhere

June 27, 2022

First Use in Commerce

June 27, 2022

Published for Opposition

June 23, 2020

Goods & Services

Pharmaceutical preparations for the treatment of cancer

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 15, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 15, 2023 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jul 14, 2023 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jul 13, 2023 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jul 12, 2023 SUPC
USE AMENDMENT FILED
Jul 6, 2023 IUAF
TEAS STATEMENT OF USE RECEIVED
Jul 6, 2023 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 1, 2023 EXRA
SOU EXTENSION 5 GRANTED
Feb 28, 2023 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 28, 2023 AITU
SOU EXTENSION 5 FILED
Feb 10, 2023 EXT5
SOU TEAS EXTENSION RECEIVED
Feb 10, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 19, 2022 EXRA
SOU EXTENSION 4 GRANTED
Aug 17, 2022 EX4G
SOU EXTENSION 4 FILED
Aug 17, 2022 EXT4
SOU TEAS EXTENSION RECEIVED
Aug 17, 2022 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 7, 2022 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jul 7, 2022 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 7, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 7, 2022 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 15, 2022 EXRA
SOU EXTENSION 3 GRANTED
Feb 11, 2022 EX3G
SOU EXTENSION 3 FILED
Feb 11, 2022 EXT3
SOU TEAS EXTENSION RECEIVED
Feb 11, 2022 EEXT
ASSIGNED TO EXAMINER
Feb 1, 2022 DOCK
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 11, 2021 EXRA
SOU EXTENSION 2 GRANTED
Aug 9, 2021 EX2G
SOU EXTENSION 2 FILED
Aug 9, 2021 EXT2
SOU TEAS EXTENSION RECEIVED
Aug 9, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 19, 2021 EXRA
SOU EXTENSION 1 GRANTED
Feb 17, 2021 EX1G
SOU EXTENSION 1 FILED
Feb 17, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Feb 17, 2021 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 18, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 23, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jun 23, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 3, 2020 NONP
ASSIGNED TO LIE
May 14, 2020 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
May 11, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 7, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 6, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 6, 2020 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Nov 7, 2019 GPRN
PRIORITY ACTION E-MAILED
Nov 7, 2019 GPRA
PRIORITY ACTION WRITTEN
Nov 7, 2019 CPRA
ASSIGNED TO EXAMINER
Nov 7, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 25, 2019 NWOS
NEW APPLICATION ENTERED
Aug 12, 2019 NWAP

Related Trademarks

More from this Owner

P PHIO PHARMACEUTICALS logo

P PHIO PHARMACEUTICALS

PHIO PHARMACEUTICALS

PHIO PHARMACEUTICALS

DERMAPEX

DERMAPEX

DERMARK

DERMARK

DERMARK

DERMARK

DERMAPEX

DERMAPEX